Catalog3 refs
Cardiogen (AEDR)
BioregulatorsResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
Circulationcell nucleusDNA
Overview
A Khavinson bioregulator peptide consisting of four amino acids (AEDR), derived from heart tissue research. It penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression epigenetically, supporting cardiac tissue repair and improving cardiovascular function.
Primary Uses
Supports cardiac tissue repair and regeneration
Regulates cardiovascular gene expression
Improves myocardial function
May support post-cardiac event recovery
Addresses age-related cardiovascular decline
Part of comprehensive anti-aging protocols
Protocol Reference
Dose
10-20 mg daily
Frequency
Once daily for 10-20 consecutive days; 2-3 cycles per year for maintenance
Half-life
Minutes (short peptide); effects persist via epigenetic changes
Route
Oral capsules · Injectable (lyophilized)
Evidence
Moderate Research
Research Models
Human
Also in Bioregulators